Fullerton Fund Management CO Ltd. Abbott Laboratories Transaction History

Fullerton Fund Management CO Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $224,453 - $248,311	-1,924 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $128,111 - $150,805	-1,211 Reduced 38.63%	1,924 $223,000
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $116,894 - $137,719	-1,074 Reduced 25.52%	3,135 $376,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $259,875 - $283,189	2,475 Added 142.73%	4,209 $461,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $158,903 - $192,976	1,734 New	1,734 $189,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.